Van Hulzen Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-93
| Closed | -$48.4K | – | 1035 |
|
|
2024
Q4 | $48.4K | Buy |
+93
| New | +$48.4K | ﹤0.01% | 506 |
|
|
2023
Q4 | – | Sell |
-461
| Closed | -$233K | – | 320 |
|
|
2023
Q3 | $233K | Sell |
461
-575
| -56% | -$291K | 0.02% | 275 |
|
|
2023
Q2 | $541K | Buy |
1,036
+250
| +32% | +$131K | 0.05% | 177 |
|
|
2023
Q1 | $453K | Sell |
786
-79
| -9% | -$45.5K | 0.04% | 189 |
|
|
2022
Q4 | $476K | Hold |
865
| – | – | 0.05% | 180 |
|
|
2022
Q3 | $439K | Hold |
865
| – | – | 0.05% | 178 |
|
|
2022
Q2 | $470K | Hold |
865
| – | – | 0.06% | 172 |
|
|
2022
Q1 | $511K | Sell |
865
-194
| -18% | -$115K | 0.05% | 168 |
|
|
2021
Q4 | $707K | Hold |
1,059
| – | – | 0.08% | 145 |
|
|
2021
Q3 | $605K | Hold |
1,059
| – | – | 0.09% | 127 |
|
|
2021
Q2 | $534K | Hold |
1,059
| – | – | 0.08% | 138 |
|
|
2021
Q1 | $483K | Sell |
1,059
-204
| -16% | -$93K | 0.08% | 148 |
|
|
2020
Q4 | $588K | Sell |
1,263
-51
| -4% | -$23.7K | 0.09% | 124 |
|
|
2020
Q3 | $580K | Sell |
1,314
-2,206
| -63% | -$974K | 0.09% | 117 |
|
|
2020
Q2 | $1.28M | Buy |
3,520
+2,200
| +167% | +$797K | 0.19% | 80 |
|
|
2020
Q1 | $374K | Hold |
1,320
| – | – | 0.08% | 146 |
|
|
2019
Q4 | $429K | Sell |
1,320
-31
| -2% | -$10.1K | 0.08% | 167 |
|
|
2019
Q3 | $394K | Hold |
1,351
| – | – | 0.08% | 172 |
|
|
2019
Q2 | $397K | Buy |
1,351
+154
| +13% | +$45.3K | 0.09% | 163 |
|
|
2019
Q1 | $328K | Buy |
1,197
+36
| +3% | +$9.87K | 0.09% | 161 |
|
|
2018
Q4 | $260K | Buy |
1,161
+31
| +3% | +$6.94K | 0.08% | 186 |
|
|
2018
Q3 | $276K | Buy |
+1,130
| New | +$276K | 0.07% | 177 |
|